Bausch + Lomb Corporation (TSX:BLCO)
27.94
-0.81 (-2.82%)
Oct 30, 2026, 3:51 PM EDT
Bausch + Lomb Employees
Bausch + Lomb had 13,000 employees as of December 31, 2025. The number of employees decreased by 500 or 3.70% compared to the previous year.
Employees
13,000
Change (1Y)
-500
Growth (1Y)
-3.70%
Revenue / Employee
591.67K CAD
Profits / Employee
-12.12K CAD
Market Cap
9.98B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13,000 | -500 | -3.70% |
| Dec 31, 2024 | 13,500 | 200 | 1.50% |
| Dec 31, 2023 | 13,300 | 400 | 3.10% |
| Dec 31, 2022 | 12,900 | 400 | 3.20% |
| Dec 31, 2021 | 12,500 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 4,900 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
| Cronos Group | 610 |
Bausch + Lomb News
- 1 day ago - Bausch + Lomb price target raised to $20 from $16 at Deutsche Bank - TheFly
- 1 day ago - Bausch + Lomb price target raised to $22 from $16 at JPMorgan - TheFly
- 2 days ago - Bausch + Lomb announces publication of results from survey on dry eye symptoms - TheFly
- 2 days ago - Bausch + Lomb price target raised to $23 from $21 at Citi - TheFly
- 2 days ago - Bausch + Lomb Announces Publication of Multinational Survey Results Highlighting the Burden of Dry Eye Symptoms and Opportunities for Improved Awareness and Patient Education - Business Wire
- 3 days ago - Bausch + Lomb Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Bausch + Lomb Slides: Q3 2026 - Filings
- 3 days ago - Bausch + Lomb Earnings release: Q3 2026 - Filings